Clinical Trial Update: Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating cilostazol for coronary artery disease in patients with type 2 diabetes mellitus has completed, assessing coronary stenosis and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED